共 50 条
- [46] Successful Treatment of Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid with Omalizumab: A Case Report and Review of the Literature CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 2865 - 2874
- [48] Solar urticaria, a disease with many dark sides: is omalizumab the right therapeutic response? Reflections from a clinical case report OPEN MEDICINE, 2019, 14 (01): : 403 - 406
- [49] Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (04): : 269 - 271